Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$84.7M
9M shares
52-week range
$4.41 – $10.50
91% from low
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
CS
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
www.electrocore.comNo one on the platform currently holds ECOR.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 44,409 | $267.8K |
| Execution date | Ratio |
|---|---|
| 2023-02-15 | 1-for-15reverse |
| 2022-12-16 | 1.001-for-1 |
No one on the platform has traded ECOR yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$ECOR Stick with this one, people. I think we can hit 20 on the next earnings report.
View on StockTwits ↗$ECOR made it through https://www.instagram.com/p/DbYeLsikWQ_/?img_index=9&igsh=NnByMDg3M2J6cnQ2
View on StockTwits ↗$ECOR the problem for bears is idk who’s left to sell. Sure the company will sell through the ATM but they raised so much last q they can take a break. Anyone else who wants out is out.
View on StockTwits ↗$ECOR Let's make sure Joshua Lev and the board know about this development in Japan https://www.instagram.com/p/DbvzNPeETaa/?img_index=7&igsh=MTE3NnQ2ZTBkMXhqcg==
View on StockTwits ↗PRISM Mid-Day Movers: Comms & Media and Aerospace & Defense are Today’s Leaders. PubMatic, Inc. (NASDAQ: $PUBM ) is surging in after-hours trading, with shares up about 34% to 18.17 following its second-quarter results. AgEagle Aerial Systems, Inc. (NYSE: $UAVS ) is surging today, up 27.92% to 0.919 after closing at 0.7184. Shares opened at 0.85, traded as high as 0.9588, and have already changed hands more than 8.7 million times—over four times their recent average daily volume. Other Notable Movers: FIGS Inc ( $FIGS) up 26% electroCore, Inc. ( $ECOR) up 23% Xponential Fitness, Inc. ( $XPOF ) down -20% Disclaimer: Stock prices and percentage changes are as of 11:50 p.m. ET on August 7, 2026, and are subject to change throughout the trading day. Market data may be delayed, and intraday price movements can change rapidly. Please verify current quotes with your broker or financial data provider before making any investment decisions. https://prismmarketview.com/prism-mid-day-movers-comms-media-and-aerospace-defense-are-todays-leaders/
View on StockTwits ↗$ECOR lots of positives from that report and call: - raised full year guidance to >30% while showing continued improvement on operating leverage. Pushed out positive adjusted ebitda until next year but the losses are shrinking and it simply reflects a choice to push for growth. - raised $4 million through atm at prices above $8 - quell is growing nicely and has lots of potential - Fox is reorganizing the VA channel which he was hired to do and making progress in other channels. These sticky sales channels at high margins are the real value drivers for the company I’d expect them to lay off the ATM for rest of this quarter and for stock to trend back towards $10 into the q3 report
View on StockTwits ↗$ECOR Quell continues to impress! Truvaga didn’t. As for the structural changes, we’ll have to see how these plans improve future results. Then raising their guidance is really good news especially as after a flat quarter-to-quarter. That means these expect 11 to 12 million for both q3 and q4.
View on StockTwits ↗$ECOR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.33 up 25.00% YoY • Reported revenue of $9.45M up 28.03% YoY • electroCore is raising its full-year 2026 revenue guidance to greater than 30% annual growth over full-year 2025 and expects to achieve positive Adjusted EBITDA in the third quarter of 2027.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $42M | +31.3% | $-1.48 | $-1.53–$-1.43 | — | 4 |
| 2027 | $54M | +28.6% | $-0.43 | $-0.48–$-0.37 | — | 3 |
| 2028 | $70M | +29.8% | $0.56 | $-0.14–$1.26 | 17.7× | 2 |
| 2029 | $75M | +6.8% | $0.36 | $0.34–$0.39 | 27.6× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $-0.42 | $-0.33 | +21.8% |
| 2026-05-06 | $-0.59 | $-0.59 | +0.0% |
| 2026-03-19 | $-0.35 | $-0.34 | +2.9% |
| 2025-11-05 | $-0.36 | $-0.40 | -11.1% |
| 2025-08-06 | $-0.32 | $-0.35 | -9.4% |
| 2025-05-07 | $-0.56 | $-0.47 | +16.1% |
| 2025-03-12 | $-0.34 | $-0.40 | -17.6% |
| 2024-11-13 | $-0.29 |
| $-0.31 |
| -6.9% |
| $58M |
| — |
| NMTCNeuroOne Medical Technologies Corporation | $1.79 | -2.19% | $16M | — |
| PYPDPolyPid Ltd. | $4.73 | -1.05% | $90M | — |
Source: Financial Modeling Prep · peers by sector/industry